Valuation: Vitrolife AB

Market Cap 12.43B 1.24B 1.1B 1.03B 936M 1.77B 119B 1.78B 4.82B 60.88B 4.65B 4.55B 195B P/E 2026 *
25.2x
P/E 2027 * 20.4x
Enterprise Value 12.98B 1.29B 1.15B 1.07B 978M 1.84B 124B 1.86B 5.03B 63.57B 4.86B 4.75B 204B EV / Sales 2026 *
3.75x
EV / Sales 2027 * 3.35x
Free-Float
54.39%
Yield 2026 *
1.2%
Yield 2027 * 1.37%
1 day-1.13%
1 week-1.50%
Current month-3.47%
1 month-2.91%
3 months-0.16%
6 months-1.02%
Current year-32.99%
1 week 91.05
Extreme 91.05
95.6
1 month 88.8
Extreme 88.8
96.5
Current year 84
Extreme 84
139.6
1 year 84
Extreme 84
153.5
3 years 84
Extreme 84
268
5 years 84
Extreme 84
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 01/08/2023
Director of Finance/CFO 55 10/10/2025
Chief Investment Officer 40 -
Director TitleAgeSince
Director/Board Member 63 19/04/2013
Chairman 70 01/08/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap. Importance
6/2/26 Buy

Chief Operating Officer

6,470 0.0048%
6/2/26 Buy

Chief Executive Officer

3,013 0.0022%
4/2/26 Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-1.13%-1.50%-32.85%-34.85% 1.24B
+0.84%-3.74%-26.69%+1.85% 169B
-0.07%-2.55%-9.53%+11.07% 110B
+0.90%+1.13%-24.83%+0.58% 106B
-1.24%-0.76%-49.04%-12.75% 73.87B
-0.24%+0.69%+0.16%+72.58% 58.98B
-0.86%+2.96%+13.57%+59.50% 51.28B
-0.71%-3.82%-7.72%-31.41% 48.16B
+0.12%-0.17%-18.21%+20.29% 40.84B
-1.01%-1.45%+28.48%-9.72% 32.21B
Average -0.34%-1.07%-12.67%+7.71% 69.14B
Weighted average by Cap. +0.02%-1.46%-16.39%+10.05%

Financials

2026 *2027 *
Net sales 3.46B 345M 306M 286M 260M 491M 33.12B 496M 1.34B 16.93B 1.29B 1.27B 54.34B 3.71B 369M 328M 306M 279M 527M 35.51B 531M 1.44B 18.15B 1.39B 1.36B 58.26B
Net income 493M 49.08M 43.6M 40.7M 37.09M 69.96M 4.72B 70.61M 191M 2.41B 184M 180M 7.74B 609M 60.66M 53.89M 50.3M 45.85M 86.47M 5.83B 87.28M 236M 2.98B 228M 223M 9.57B
Net Debt 549M 54.71M 48.61M 45.37M 41.35M 77.99M 5.26B 78.72M 213M 2.69B 205M 201M 8.63B -26.74M -2.66M -2.37M -2.21M -2.01M -3.8M -256M -3.83M -10.36M -131M -10M -9.79M -420M
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
02/10/26 SEK 91.80 -1.13% 68,712
01/10/26 SEK 92.85 -2.37% 72,119
30/09/26 SEK 95.10 +3.15% 115,136
29/09/26 SEK 92.20 -0.32% 198,962
28/09/26 SEK 92.50 -0.75% 65,602
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
91.80SEK
Average target price
129.60SEK
Spread / Average Target
+41.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock